美诺华(603538.SH)：枸橼酸莫沙必利片完成药品注册

Core Viewpoint - Meihua's subsidiary, Ningbo Meihua Tiankang Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the registration certificate of Mosapride Citrate Tablets, which are indicated for improving gastrointestinal symptoms caused by reduced gastrointestinal motility [1] Group 1 - The approved drug is intended for symptoms such as heartburn, belching, nausea, vomiting, early satiety, upper abdominal distension, and upper abdominal pain [1]